| Year |
Citation |
Score |
| 2023 |
Donelan W, Brisbane W, O'Malley P, Crispen P, Kusmartsev S. Hyaluronan Metabolism in Urologic Cancers. Advanced Biology. e2300168. PMID 37615259 DOI: 10.1002/adbi.202300168 |
0.366 |
|
| 2023 |
Donelan W, Crispen PL, Kusmartsev S. Tissue Slice Culture and Analysis of Tumor-Associated Hyaluronan in Urothelial Carcinoma. Methods in Molecular Biology (Clifton, N.J.). 2684: 167-175. PMID 37410234 DOI: 10.1007/978-1-0716-3291-8_10 |
0.349 |
|
| 2023 |
Kusmartsev S, Ku JH, Grizzi F. Editorial: Tumor microenvironment in bladder cancer. Frontiers in Oncology. 13: 1208196. PMID 37207141 DOI: 10.3389/fonc.2023.1208196 |
0.333 |
|
| 2022 |
Donelan W, Dominguez-Gutierrez PR, Kusmartsev S. Deregulated hyaluronan metabolism in the tumor microenvironment drives cancer inflammation and tumor-associated immune suppression. Frontiers in Immunology. 13: 971278. PMID 36238286 DOI: 10.3389/fimmu.2022.971278 |
0.728 |
|
| 2022 |
Dominguez-Gutierrez PR, Kwenda EP, Donelan W, Miranda M, Doty A, O'Malley P, Crispen PL, Kusmartsev S. Detection of PD-L1-Expressing Myeloid Cell Clusters in the Hyaluronan-Enriched Stroma in Tumor Tissue and Tumor-Draining Lymph Nodes. Journal of Immunology (Baltimore, Md. : 1950). PMID 35589125 DOI: 10.4049/jimmunol.2100026 |
0.717 |
|
| 2022 |
Kusmartsev S, Kwenda E, Dominguez-Gutierrez PR, Crispen PL, O'Malley P. High Levels of PD-L1 and Hyal2 Myeloid-derived Suppressor Cells in Renal Cell Carcinoma. Journal of Kidney Cancer and Vhl. 9: 1-6. PMID 35528727 DOI: 10.15586/jkcvhl.v9i2.208 |
0.737 |
|
| 2021 |
Kusmartsev S, Serafini P, Bharadwaj SN, Kortylewski M. Editorial: Roles of Tumor-Recruited Myeloid Cells in Immune Evasion in Cancer. Frontiers in Immunology. 12: 749605. PMID 34512674 DOI: 10.3389/fimmu.2021.749605 |
0.403 |
|
| 2020 |
Dominguez Gutierrez PR, Kwenda EP, Donelan W, O'Malley P, Crispen PL, Kusmartsev S. Hyal2 expression in tumor-associated myeloid cells mediates cancer-related inflammation in bladder cancer. Cancer Research. PMID 33239427 DOI: 10.1158/0008-5472.CAN-20-1144 |
0.438 |
|
| 2020 |
Dominguez-Gutierrez* P, Kwenda E, Donelan W, OʼMalley P, Crispen P, Kusmartsev S. MP17-05 MYELOID CELLS IN BLADDER CANCER MICROENVIRONMENT DEGRADE HYALURONIC ACID INTO INFLAMMATORY LOW MOLECULAR WEIGHT HYALURON The Journal of Urology. 203: e227. DOI: 10.1097/Ju.0000000000000842.05 |
0.685 |
|
| 2019 |
Crispen PL, Kusmartsev S. Mechanisms of immune evasion in bladder cancer. Cancer Immunology, Immunotherapy : Cii. PMID 31811337 DOI: 10.1007/S00262-019-02443-4 |
0.446 |
|
| 2018 |
Dominguez-Gutierrez PR, Kusmartsev S, Canales BK, Khan SR. Calcium Oxalate Differentiates Human Monocytes Into Inflammatory M1 Macrophages. Frontiers in Immunology. 9: 1863. PMID 30186283 DOI: 10.3389/Fimmu.2018.01863 |
0.712 |
|
| 2017 |
Prima V, Kaliberova LN, Kaliberov S, Curiel DT, Kusmartsev S. COX2/mPGES1/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells. Proceedings of the National Academy of Sciences of the United States of America. PMID 28096371 DOI: 10.1073/Pnas.1612920114 |
0.48 |
|
| 2017 |
Kusmartsev S, Vieweg J, Prima V. Development of human NKG2D-CD3ε chimeric antigen receptor (CAR) for T-cell-mediated cancer immunotherapy. Journal of Clinical Oncology. 35: 150-150. DOI: 10.1200/Jco.2017.35.7_Suppl.150 |
0.435 |
|
| 2017 |
Dominguez-Gutierrez P, Kusmartsev S, Canales B, Khan S. MP12-18 CALCIUM OXALATE AND HYDROXYAPATITE HAVE OPPOSITE EFFECTS ON HUMAN MACROPHAGE DIFFERENTIATION Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.440 |
0.69 |
|
| 2016 |
Dominguez Gutierrez P, Kusmartsev S, Canales B, Bird V, Vieweg J, Khan S. MP58-09 HYDROXYAPATITE INDUCES CALCIUM OXALATE TOLERANCE IN PRIMARY HUMAN MONOCYTES Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.807 |
0.378 |
|
| 2015 |
Kusmartsev S, Dominguez-Gutierrez PR, Canales BK, Bird VG, Vieweg J, Khan SR. Calcium Oxalate Stone Fragment and Crystal Phagocytosis by Human Macrophages. The Journal of Urology. PMID 26626217 DOI: 10.1016/J.Juro.2015.11.048 |
0.705 |
|
| 2015 |
Prima V, Kusmartsev S, Vieweg J. Abstract B13: Prostate cancer immunotherapy development using tumor-specific CAR design Cancer Immunology Research. 3. DOI: 10.1158/2326-6074.Tumimm14-B13 |
0.426 |
|
| 2015 |
Kusmartsev S, Dominguez Gutierrez P, Canales B, Vieweg J, Khan S. MP33-09 HUMAN MONOCYTE-DERIVED MACROPHAGES ARE ABLE TO DESTROY KIDNEY STONES Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.570 |
0.403 |
|
| 2014 |
Kusmartsev S, Dominguez Gutierrez P, Canales B, Vieweg J, Khan S. MP25-12 HUMAN MACROPHAGES FACILITATE KIDNEY STONE CLEARANCES Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.314 |
0.395 |
|
| 2013 |
Eruslanov E, Stoffs T, Kim WJ, Daurkin I, Gilbert SM, Su LM, Vieweg J, Daaka Y, Kusmartsev S. Expansion of CCR8+ inflammatory myeloid cells in cancer patients with urothelial and renal carcinomas Clinical Cancer Research. 19: 1670-1680. PMID 23363815 DOI: 10.1158/1078-0432.Ccr-12-2091 |
0.518 |
|
| 2012 |
Kusmartsev S. Enhanced 15-lipoxygenase activity and elevated eicosanoid production in kidney tumor microenvironment contribute to the inflammation and immune suppression. Oncoimmunology. 1: 249-251. PMID 22720260 DOI: 10.4161/Onci.1.2.18502 |
0.531 |
|
| 2012 |
Eruslanov E, Neuberger M, Daurkin I, Perrin GQ, Algood C, Dahm P, Rosser C, Vieweg J, Gilbert SM, Kusmartsev S. Circulating and tumor-infiltrating myeloid cell subsets in patients with bladder cancer International Journal of Cancer. 130: 1109-1119. PMID 21480223 DOI: 10.1002/Ijc.26123 |
0.468 |
|
| 2011 |
Daurkin I, Eruslanov E, Stoffs T, Perrin GQ, Algood C, Gilbert SM, Rosser CJ, Su LM, Vieweg J, Kusmartsev S. Tumor-associated macrophages mediate immunosuppression in the renal cancer microenvironment by activating the 15-lipoxygenase-2 pathway Cancer Research. 71: 6400-6409. PMID 21900394 DOI: 10.1158/0008-5472.Can-11-1261 |
0.503 |
|
| 2011 |
Eruslanov E, Daurkin I, Vieweg J, Daaka Y, Kusmartsev S. Aberrant PGE₂ metabolism in bladder tumor microenvironment promotes immunosuppressive phenotype of tumor-infiltrating myeloid cells. International Immunopharmacology. 11: 848-55. PMID 21315786 DOI: 10.1016/J.Intimp.2011.01.033 |
0.53 |
|
| 2010 |
Eruslanov E, Daurkin I, Ortiz J, Vieweg J, Kusmartsev S. Pivotal Advance: Tumor-mediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE₂ catabolism in myeloid cells. Journal of Leukocyte Biology. 88: 839-48. PMID 20587738 DOI: 10.1189/Jlb.1209821 |
0.493 |
|
| 2010 |
Daurkin I, Eruslanov E, Vieweg J, Kusmartsev S. Generation of antigen-presenting cells from tumor-infiltrated CD11b myeloid cells with DNA demethylating agent 5-aza-2'-deoxycytidine. Cancer Immunology, Immunotherapy : Cii. 59: 697-706. PMID 19882154 DOI: 10.1007/S00262-009-0786-4 |
0.482 |
|
| 2009 |
Kusmartsev S, Vieweg J. Enhancing the efficacy of cancer vaccines in urologic oncology: new directions. Nature Reviews. Urology. 6: 540-9. PMID 19736551 DOI: 10.1038/Nrurol.2009.177 |
0.352 |
|
| 2009 |
Porvasnik S, Sakamoto N, Kusmartsev S, Eruslanov E, Kim WJ, Cao W, Urbanek C, Wong D, Goodison S, Rosser CJ. Effects of CXCR4 antagonist CTCE-9908 on prostate tumor growth. The Prostate. 69: 1460-9. PMID 19588526 DOI: 10.1002/Pros.21008 |
0.323 |
|
| 2009 |
Eruslanov E, Kaliberov S, Daurkin I, Kaliberova L, Buchsbaum D, Vieweg J, Kusmartsev S. Altered expression of 15-hydroxyprostaglandin dehydrogenase in tumor-infiltrated CD11b myeloid cells: A mechanism for immune evasion in cancer Journal of Immunology. 182: 7548-7557. PMID 19494278 DOI: 10.4049/Jimmunol.0802358 |
0.497 |
|
| 2009 |
Corzo CA, Cotter MJ, Cheng P, Cheng F, Kusmartsev S, Sotomayor E, Padhya T, McCaffrey TV, McCaffrey JC, Gabrilovich DI. Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells. Journal of Immunology (Baltimore, Md. : 1950). 182: 5693-701. PMID 19380816 DOI: 10.4049/Jimmunol.0900092 |
0.474 |
|
| 2009 |
Sakai Y, Goodison S, Kusmartsev S, Fletcher B, Eruslanov E, Cao W, Porvasnik S, Namiki K, Anai S, Rosser CJ. Bcl-2 mediated modulation of vascularization in prostate cancer xenografts. The Prostate. 69: 459-70. PMID 19107861 DOI: 10.1016/S0022-5347(09)61346-X |
0.318 |
|
| 2008 |
Kusmartsev S, Su Z, Heiser A, Dannull J, Eruslanov E, Kübler H, Yancey D, Dahm P, Vieweg J. Reversal of myeloid cell - mediated immunosuppression in patients with metastatic renal cell carcinoma Clinical Cancer Research. 14: 8270-8278. PMID 19088044 DOI: 10.1158/1078-0432.Ccr-08-0165 |
0.406 |
|
| 2008 |
Kusmartsev S, Eruslanov E, Kübler H, Tseng T, Sakai Y, Su Z, Kaliberov S, Heiser A, Rosser C, Dahm P, Siemann D, Vieweg J. Oxidative stress regulates expression of VEGFR1 in myeloid cells: link to tumor-induced immune suppression in renal cell carcinoma. Journal of Immunology (Baltimore, Md. : 1950). 181: 346-53. PMID 18566400 DOI: 10.4049/Jimmunol.181.1.346 |
0.451 |
|
| 2007 |
Vieweg J, Su Z, Dahm P, Kusmartsev S. Reversal of tumor-mediated immunosuppression. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 727s-732s. PMID 17255301 DOI: 10.1158/1078-0432.Ccr-06-1924 |
0.35 |
|
| 2006 |
Kusmartsev S, Gabrilovich DI. Effect of tumor-derived cytokines and growth factors on differentiation and immune suppressive features of myeloid cells in cancer. Cancer Metastasis Reviews. 25: 323-31. PMID 16983515 DOI: 10.1007/S10555-006-9002-6 |
0.485 |
|
| 2006 |
Kusmartsev S, Gabrilovich DI. Role of immature myeloid cells in mechanisms of immune evasion in cancer. Cancer Immunology, Immunotherapy : Cii. 55: 237-45. PMID 16047143 DOI: 10.1007/S00262-005-0048-Z |
0.518 |
|
| 2005 |
Kusmartsev S, Nagaraj S, Gabrilovich DI. Tumor-associated CD8+ T cell tolerance induced by bone marrow-derived immature myeloid cells. Journal of Immunology (Baltimore, Md. : 1950). 175: 4583-92. PMID 16177103 DOI: 10.4049/Jimmunol.175.7.4583 |
0.43 |
|
| 2005 |
Kusmartsev S, Gabrilovich DI. STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion. Journal of Immunology (Baltimore, Md. : 1950). 174: 4880-91. PMID 15814715 DOI: 10.4049/Jimmunol.174.8.4880 |
0.48 |
|
| 2005 |
Gabrilovich D, Nagaraj S, Kusmartsev S. Tumor Associated CD8+ T-Cell Tolerance Induced by Bone Marrow Derived Immature Myeloid Cells Journal of Immunotherapy. 28: 648. DOI: 10.1097/01.Cji.0000191065.34501.E3 |
0.371 |
|
| 2004 |
Kusmartsev S, Nefedova Y, Yoder D, Gabrilovich DI. Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. Journal of Immunology (Baltimore, Md. : 1950). 172: 989-99. PMID 14707072 DOI: 10.4049/Jimmunol.172.2.989 |
0.415 |
|
| 2004 |
Nefedova Y, Huang M, Kusmartsev S, Bhattacharya R, Cheng P, Salup R, Jove R, Gabrilovich D. Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer. Journal of Immunology (Baltimore, Md. : 1950). 172: 464-74. PMID 14688356 DOI: 10.4049/Jimmunol.172.1.464 |
0.45 |
|
| 2003 |
Kusmartsev S, Cheng F, Yu B, Nefedova Y, Sotomayor E, Lush R, Gabrilovich D. All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination. Cancer Research. 63: 4441-9. PMID 12907617 |
0.378 |
|
| 2003 |
Kusmartsev S, Gabrilovich DI. Inhibition of myeloid cell differentiation in cancer: the role of reactive oxygen species. Journal of Leukocyte Biology. 74: 186-96. PMID 12885935 DOI: 10.1189/Jlb.0103010 |
0.442 |
|
| 2002 |
Kusmartsev S, Gabrilovich DI. Immature myeloid cells and cancer-associated immune suppression. Cancer Immunology, Immunotherapy : Cii. 51: 293-8. PMID 12111117 DOI: 10.1007/S00262-002-0280-8 |
0.473 |
|
| 2000 |
Kusmartsev S, Ruiz de Morales JM, Rullas J, Danilets MG, Subiza JL. Sialoadhesin expression by bone marrow macrophages derived from Ehrlich-tumor-bearing mice. Cancer Immunology, Immunotherapy : Cii. 48: 493-8. PMID 10602886 DOI: 10.1007/S002620050597 |
0.456 |
|
| Show low-probability matches. |